{"id":"https://openalex.org/W2082016554","doi":"https://doi.org/10.1016/0165-6147(93)90185-m","title":"Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents","display_name":"Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents","publication_year":1993,"publication_date":"1993-12-01","ids":{"openalex":"https://openalex.org/W2082016554","doi":"https://doi.org/10.1016/0165-6147(93)90185-m","mag":"2082016554","pmid":"https://pubmed.ncbi.nlm.nih.gov/8122313"},"language":"en","primary_location":{"id":"doi:10.1016/0165-6147(93)90185-m","doi":"https://doi.org/10.1016/0165-6147(93)90185-m","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0165-6147(93)90185-m","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2082016554"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110009421","display_name":"Allan Fletcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allan Fletcher","raw_affiliation_strings":["Wyeth Research, Berkshire, UK","A. Fletcher is Section Head of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","C.T. Dourish is Director of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","I.A. Cliffe is Research Fellow in Medicinal Chemistry Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, Berkshire, UK","institution_ids":[]},{"raw_affiliation_string":"A. Fletcher is Section Head of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]},{"raw_affiliation_string":"C.T. Dourish is Director of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]},{"raw_affiliation_string":"I.A. Cliffe is Research Fellow in Medicinal Chemistry Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059674202","display_name":"Ian A. Cliffe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian A. Cliffe","raw_affiliation_strings":["A. Fletcher is Section Head of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","C.T. Dourish is Director of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","I.A. Cliffe is Research Fellow in Medicinal Chemistry Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A. Fletcher is Section Head of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]},{"raw_affiliation_string":"C.T. Dourish is Director of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]},{"raw_affiliation_string":"I.A. Cliffe is Research Fellow in Medicinal Chemistry Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089441909","display_name":"Colin Trevor Dourish","orcid":"https://orcid.org/0000-0002-3403-6330","observed_orcids":["https://orcid.org/0000-0002-3403-6330"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin T. Dourish","raw_affiliation_strings":["A. Fletcher is Section Head of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","C.T. Dourish is Director of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","I.A. Cliffe is Research Fellow in Medicinal Chemistry Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A. Fletcher is Section Head of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]},{"raw_affiliation_string":"C.T. Dourish is Director of Neuropharmacology, Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]},{"raw_affiliation_string":"I.A. Cliffe is Research Fellow in Medicinal Chemistry Wyeth Research (UK), Huntercombe Lane South, Taplow, Maidenhead, Berkshire, UK SL6 OPH","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":7030,"currency":"USD","value_usd":7030},"apc_paid":null,"fwci":2.5555,"has_fulltext":false,"cited_by_count":195,"citation_normalized_percentile":{"value":0.9197861,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"14","issue":"12","first_page":"441","last_page":"448"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8734999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8734999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.1006999984383583,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.02199999988079071,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.9950000047683716},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.9110000133514404},{"id":"https://openalex.org/keywords/serotonin-receptor-pharmacology","display_name":"serotonin receptor pharmacology","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C8439214","wikidata":"https://www.wikidata.org/wiki/Q417749","display_name":"Autoreceptor","level":4,"score":0.7261486053466797},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.7190169095993042},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.6969341039657593},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6056355237960815},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5550416707992554},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5368614196777344},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.48160454630851746},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.46895426511764526},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46771493554115295},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3977465033531189},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.3422466516494751},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2788432836532593},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2439729869365692},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2332453727722168},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12311705946922302}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0165-6147(93)90185-m","doi":"https://doi.org/10.1016/0165-6147(93)90185-m","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0165-6147(93)90185-m","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:8122313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8122313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in pharmacological sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W8555371","https://openalex.org/W580067020","https://openalex.org/W1964055210","https://openalex.org/W1965349885","https://openalex.org/W1966377499","https://openalex.org/W1966772380","https://openalex.org/W1968773591","https://openalex.org/W1972882218","https://openalex.org/W1973285360","https://openalex.org/W1975064270","https://openalex.org/W1975415791","https://openalex.org/W1977895567","https://openalex.org/W1981818755","https://openalex.org/W1983336401","https://openalex.org/W1983467397","https://openalex.org/W1984155228","https://openalex.org/W1984642996","https://openalex.org/W1988379117","https://openalex.org/W1988658197","https://openalex.org/W1989788228","https://openalex.org/W1998124430","https://openalex.org/W1998519813","https://openalex.org/W1999445315","https://openalex.org/W2001850627","https://openalex.org/W2003685027","https://openalex.org/W2005484176","https://openalex.org/W2007682162","https://openalex.org/W2013283830","https://openalex.org/W2013688328","https://openalex.org/W2020460680","https://openalex.org/W2020644384","https://openalex.org/W2039977990","https://openalex.org/W2044566539","https://openalex.org/W2046994328","https://openalex.org/W2054111879","https://openalex.org/W2058092335","https://openalex.org/W2065095084","https://openalex.org/W2081047826","https://openalex.org/W2084269334","https://openalex.org/W2086174713","https://openalex.org/W2086177468","https://openalex.org/W2091980743","https://openalex.org/W2092948253","https://openalex.org/W2111965328","https://openalex.org/W2137950391","https://openalex.org/W2138340537","https://openalex.org/W2280684008","https://openalex.org/W2314661953","https://openalex.org/W2337664708","https://openalex.org/W2341140535","https://openalex.org/W2404237503","https://openalex.org/W2408477947","https://openalex.org/W2417231731","https://openalex.org/W2465509789"],"related_works":["https://openalex.org/W2092098669","https://openalex.org/W156547202","https://openalex.org/W1963690073","https://openalex.org/W2024039857","https://openalex.org/W1970981586","https://openalex.org/W2081063617","https://openalex.org/W2172404567","https://openalex.org/W193698953","https://openalex.org/W2475149624","https://openalex.org/W2410289271"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
